While winning FDA or other regulatory approval is a formidable hurdle, it is no longer the end game when it comes to defining if the development of a product is truly successful. In today's health care reality, the new finish line is unrestricted and affordable patient access to innovative medicines and technologies that actually change the practice of medicine for unmet medical needs—from major public health challenges to orphan diseases
The new product development reality
Consultoria especializada em GMP/BPF para indústrias voltadas a Ciências da Vida!
Nenhum comentário:
Postar um comentário